Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
NCT05124925 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2026-02-02
Summary
This study aims at elucidating the mechanism of action of ianalumab in salivary glands and explore relationships with clinical assessments
Conditions
- Sjogren Syndrome
Interventions
- BIOLOGICAL
-
Ianalumab VAY736 150mg/1ml Solution for injection
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-27
- Primary Completion
- 2024-06-26
- Completion
- 2026-01-05
Countries
- France
Study Locations
More Related Trials
-
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
NCT04848870 ·Status: RECRUITING
-
Salivary Markers in Patients With Xerostomia
NCT03156569 ·Status: COMPLETED
-
Safety and Potential Effect of Innovative Cell-based Therapy Using Adipose-derived Stromal Vascular Fraction in Patients With Autoimmune Xerostomia
NCT05857358 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Olfactory and Taste Disturbances in Sjogren's Syndrome
NCT04909112 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound Elastography of Salivary Glands
NCT02994797 ·Status: COMPLETED
-
Sjogrens Syndrome Measured by Ultrasound
NCT03411850 ·Status: UNKNOWN ·Phase: PHASE2
-
Biomarkers in Saliva and Stool
NCT03297008 ·Status: TERMINATED
-
An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
NCT01369589 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Salivary Gland Dysfunction
NCT00001196 ·Status: TERMINATED
-
The Role of Central Sensitization on Biopsychosocial Factors in Primary Sjögren's Syndrome
NCT06410742 ·Status: COMPLETED
-
Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients
NCT00873496 ·Status: COMPLETED
-
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
NCT05680064 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
NCT00565526 ·Status: COMPLETED
-
Evaluation of the Reproducibility Inter-observer of the Ultrasound Anomalies of the Salivary Glands in Sjogren's Disease
NCT02358213 ·Status: COMPLETED ·Phase: NA
-
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685 ·Status: COMPLETED
-
Clinical Study New Gel for Xerostomia
NCT04184908 ·Status: UNKNOWN ·Phase: PHASE1
-
An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome
NCT06437652 ·Status: COMPLETED
-
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
NCT02049112 ·Status: COMPLETED ·Phase: PHASE4
-
Salivary Proteins in Disease and Health
NCT00100204 ·Status: COMPLETED
-
Quality of Life and Sjögren Syndrome
NCT03578900 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Interest of the Buccal Schirmer Test in Xerostomia During Sjögren's Syndrome: XERODIAG
NCT06530940 ·Status: NOT_YET_RECRUITING
-
Histopathological Analysis Versus Full-field Optical Coherence Tomography of Minor Salivary Gland Biopsy in Suspect Sjogren Syndrome
NCT06454370 ·Status: RECRUITING
-
Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
NCT01316770 ·Status: TERMINATED ·Phase: PHASE2
-
The Pathogenesis and Natural History of Sjogren's Disease
NCT01425892 ·Status: RECRUITING
-
Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population
NCT03327870 ·Status: COMPLETED